Department of Clinical Laboratory, Beijing YouAn Hospital, Capital Medical University, Beijing, P.R. China.
Department of Clinical Laboratory, Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing, P.R. China.
Clin Chem Lab Med. 2020 Jul 28;58(8):1365-1371. doi: 10.1515/cclm-2020-0411.
Objectives As people across the world suffer from coronavirus disease 2019 (COVID-19), further studies are needed to facilitate evaluating the severity and prognosis of COVID-19 patients. In the study, we aimed to dissect the dynamic profile and clinical implications of hematological findings in hospitalized patients with COVID-19. Methods We retrospectively analyzed the hematological findings of 72 patients with COVID-19 admitted from January 21 to February 17, 2020. The final date of follow-up was March 20, 2020. Dynamic profile of vital hematological parameters in severe and non-severe patients was presented at different time points (day 1, 5, 7, 9, 11, 13, 15 after admission), and the correlation of hematological parameters with hospitalization time was indicated. Results Of 72 patients with COVID-19, lymphopenia and leukopenia occurred in 39 (54.2%) and 20 (27.8%) patients with COVID-19, respectively. Fifteen (20.8%) patients were defined as severe cases and 57 (79.2%) were non-severe cases. Compared to non-severe patients, leukocyte count, neutrophil count and neutrophil-to-lymphocyte ratio (NLR) were significantly higher, whereas lymphocyte count was declined in severe patients at each time point. A growing trend in platelet count was found in non-severe patients over the follow-up period. In addition, a positive correlation of NLR with hospitalization time was detected from day 5 after admission. Conclusions Dynamic changes in vital hematological parameters from severe and non-severe patients had been characterized in the course of hospitalization. During hospitalization, NLR was found to have certain relevance to the hospitalization days and a role in forecasting disease prognosis for patients with COVID-19.
目的
随着全球各地的人们遭受 2019 年冠状病毒病(COVID-19)的折磨,需要进一步的研究来评估 COVID-19 患者的严重程度和预后。在这项研究中,我们旨在剖析住院 COVID-19 患者血液学发现的动态特征及其临床意义。
方法
我们回顾性分析了 2020 年 1 月 21 日至 2 月 17 日收治的 72 例 COVID-19 患者的血液学发现。随访的最终日期为 2020 年 3 月 20 日。在不同时间点(入院后第 1、5、7、9、11、13、15 天)呈现严重和非严重患者重要血液学参数的动态特征,并表明血液学参数与住院时间的相关性。
结果
在 72 例 COVID-19 患者中,淋巴细胞减少和白细胞减少分别发生在 39(54.2%)和 20(27.8%)例 COVID-19 患者中。15(20.8%)例患者被定义为重症病例,57(79.2%)例为非重症病例。与非重症患者相比,重症患者在每个时间点的白细胞计数、中性粒细胞计数和中性粒细胞与淋巴细胞比值(NLR)均明显升高,而淋巴细胞计数则降低。非重症患者的血小板计数在随访期间呈上升趋势。此外,从入院后第 5 天开始,NLR 与住院时间呈正相关。
结论
在住院期间,从严重和非严重患者中观察到重要血液学参数的动态变化。住院期间,NLR 与住院天数有一定相关性,对 COVID-19 患者的疾病预后有一定预测作用。